February 6, 2023
Lung Cancer Initiative awards Pecot $100,000 grant
The grant supports Chad Pecot, MD, and his research into the mechanistic and therapeutic implications of co-targeting two genes linked to lung cancer.
Tag: Chad Pecot
September 27, 2022
Protein could help identify head and neck cancers that require less intensive treatment
Adding detection of immune cell protein SYNGR3 to current protocols could lead to a more reliable way of determining which patients with head and neck cancer need less intensive treatment.
July 22, 2022
UNC Lineberger creates RNA Discovery Center
The UNC RNA Discovery Center, led by Chad Pecot, MD, will cultivate an inclusive community of scientists dedicated to investigating all aspects of RNA biology.
May 6, 2022
Leading researchers provide insights on aggressive cancers at scientific symposium
UNC Lineberger’s 45th annual Scientific Symposium featured talks on the latest research on pancreatic cancer, tumor microenvironments, metastatic disease and immunotherapy.
March 15, 2022
A patient’s decision adds immeasurably to knowledge about how to treat lung cancer
Chad Pecot, MD, and colleagues used biospecimens from a patient just after he succumbed to lung cancer to unravel how a KRAS mutation developed resistance to a treatment that had initially proved effective.
September 15, 2021
OncLive: Dr. Pecot on Selecting Between Available Targeted Therapies in NSCLC
April 22, 2021
A cancer survivor fights back
UNC Lineberger's Chad Pecot, MD — a cancer survivor himself — launched EnFuego Therapeutics with the help of UNC KickStart Venture Services to develop RNA-interference drugs that silence cancer-related gene mutations.
September 25, 2020
New vulnerability found in lung squamous cancer may facilitate drug targeting at the cellular level
New research by Chad Pecot, MD, and colleagues shows the potential for targeting a specific circular RNA, known as CDR1as, to attack lung squamous cell cancer.
April 17, 2019
New details revealed to explain how tumors recruit blood vessels
A study by University of North Carolina Lineberger Comprehensive Cancer Center researchers helps explain how tumors recruit blood vessels that provide fuel for their growth as well as an avenue for the tumors to spread. In the journal Oncogene, the researchers also reported they built on these findings to uncover a potential treatment strategy to …
February 11, 2019
UNC Lineberger awards $1.35M for cancer research
UNC Lineberger awarded grants to 14 scientists and research teams in the fall grant awards cycle. Applications for the next round of funding will be due March 15.